Introduction

Cytokine PharmaSciences is a U.S.-based biopharmaceutical company specializing in the development of anti-inflammatory and autoimmune disease treatments. Its lead compound, CPSI-2364, is an oral inhibitor that targets pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6.

Discover more